Creathor Venture — Seed & Series A VC Firm ($500K–$5.0M Checks)
Creathor Venture is a Seed, Series A venture capital firm based in Bad Homburg, Germany investing in Fintech, SaaS, Other. The firm typically writes $500K–$5.0M checks and has 69 portfolio companies in our records.
- Check size
- $500K–$5.0M
- Portfolio
- 69 companies on record
- Partners
- 4 listed
- AUM
- $1B
- Stage
- Seed, Series A
- Sectors
- Fintech, SaaS, Other, Healthcare, Consumer, EdTech, Real Estate
- HQ
- Bad Homburg, Germany
Last verified: 2026-10-21
Seed, Series A
$500K – $5.0M
$1.0B
69+ companies
4 partners
Investment Thesis
A seed and Series A investor with explicit interest in fintech, SaaS, and digital health. Its combination of software and financial-services exposure makes it relevant for a B2B analytics and trading platform.
How Creathor Venture invests
Creathor Venture is a vc firm based in Bad Homburg, Germany. The firm invests at the Seed, Series A stages, with a focus on Fintech, SaaS, Other, Healthcare, Consumer.
Creathor Venture typically writes checks of $500K–$5.0M per investment, backed by approximately $1B in assets under management. Our records include 4 funds raised by the firm.
Investing since at least 2015, Creathor Venture has backed 69 companies in our records, including Accovion, Acousia Therapeutics, ACTech. Its most recent recorded investment was in 2015.
Partners & Team
Industry Focus
Invests In
Funds
Creathor Ventures Fund IV
Creathor Ventures Fund III
Creathor Ventures Fund II
Creathor Ventures Fund I
Portfolio Companies (69)
2015
Accovion
Accovion was one of Germany’s leading clinical research organisations.
Other
Acousia Therapeutics
Acousia develops drugs which will prevent hearing loss and restore hearing in patients.
ACTech
ACTech sets new standards of rapid prototype production for the automotive, engineering and aerospace sectors, delivering high-precision, finished ready-to-install casting prototypes, produced in record time.
ADCON Telemetry
Adcon produces flexible, modular and open data transmission systems (telemetry systems and wireless devices for data transmission).
Allthings Technologies
Allthings is the new standard for tenant relationship management and new service models in buildings.
ALRISE Biosystems
ALRISE has invented an innovative, globally patented encapsulation technology for long-acting, injectable medications.
AYOXXA Biosystems
AYOXXA has developed the proprietary technology platform IEBA (In-situ Encoded Bead-based Arrays) for multiplexed protein analysis in life science research and diagnostics applications.
bitbar
Bitbar develops Testdroid, a cloud-based developer service to automate the testing of Android and iOS applications, HTML5 apps and mobile web sites on an unlimited number of physical devices simultaneously.
Blueprint Genetics
Blueprint Genetic supports health care professionals worldwide in finding the best care for patients and families with rare inherited diseases through AI-enabled clinical genetic DNA testing.
Brokat Technologies
Brokat was a leading global provider of software for e-business and internet banking as well as payment processing.
- •Raising at Seed, Series A? You're squarely in their sweet spot.
- •Lead with your fit in Fintech, SaaS, Other — the sectors they actively back.
- •Size your ask to their typical $500K – $5.0M check.
- •warm intro preferred
- •Address your outreach to a specific partner, such as Cedric Köhler, Managing Partner.
- •A warm introduction beats a cold email. Get matched and request an intro.
Featured In
Browse More Investors
Fundraising resources
Frequently Asked Questions
See if Creathor Venture is a match for your startup
Upload your pitch deck to see how well you match with Creathor Venture and 10,000+ other investors.
Ask your AI assistant about this investor: connect InvestorMatch to Claude or ChatGPT
Is this your profile? Request a correction or removal